Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Novel rapamycin derivatives reported by Novartis

Feb. 21, 1997

MedImmune's HPV vaccine enters phase I

Feb. 18, 1997

Peptide Therapeutics/SmithKline Beecham vaccine technology alliance

Feb. 18, 1997

Immunosuppressants discovered by Merck & Co.

Feb. 18, 1997

Positive phase I safety profile for Immunex's new product candidate

Feb. 14, 1997

Melatonin in immunity, aging and cancer

Feb. 12, 1997

U.S. patent issued for meningococcal B vaccine

Feb. 11, 1997

CEAPRO receives patent coverage for potential vaccine adjuvants

Feb. 7, 1997

Legionella vaccine described by U.S. researchers

Feb. 7, 1997

Clinical trial data reported for meningitis vaccine

Feb. 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 4, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...